Publications by authors named "Jamie Chau"

Claim this Profile
N
NET-02: a randomised, non-comparative, phase II trial of nal-IRI/5-FU or docetaxel as second-line therapy in patients with progressive poorly differentiated extra-pulmonary neuroendocrine carcinoma.
Mairéad G McNamara, Jayne Swain, Zoe Craig, Rohini Sharma, Olusola Faluyi, Ian Chau

EClinicalMedicine· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis